Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Utah Medical Products (UTMD) over the last 15 years, with Q3 2025 value amounting to 0.08%.

  • Utah Medical Products' Return on Invested Capital fell 200.0% to 0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.02% for FY2024, which is 0.0% changed from last year.
  • Per Utah Medical Products' latest filing, its Return on Invested Capital stood at 0.08% for Q3 2025, which was down 200.0% from 0.09% recorded in Q2 2025.
  • Utah Medical Products' 5-year Return on Invested Capital high stood at 0.15% for Q3 2022, and its period low was 0.08% during Q3 2025.
  • For the 5-year period, Utah Medical Products' Return on Invested Capital averaged around 0.12%, with its median value being 0.12% (2023).
  • Its Return on Invested Capital has fluctuated over the past 5 years, first tumbled by -400bps in 2021, then soared by 400bps in 2022.
  • Quarter analysis of 5 years shows Utah Medical Products' Return on Invested Capital stood at 0.13% in 2021, then grew by 2bps to 0.14% in 2022, then fell by -20bps to 0.11% in 2023, then decreased by -16bps to 0.09% in 2024, then decreased by -14bps to 0.08% in 2025.
  • Its last three reported values are 0.08% in Q3 2025, 0.09% for Q2 2025, and 0.09% during Q1 2025.